List of Tables
Table 1. Engineered Cell Therapy Market Trends
Table 2. Engineered Cell Therapy Market Drivers & Opportunity
Table 3. Engineered Cell Therapy Market Challenges
Table 4. Engineered Cell Therapy Market Restraints
Table 5. Global Engineered Cell Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Engineered Cell Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Engineered Cell Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Engineered Cell Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Engineered Cell Therapy
Table 10. Global Engineered Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered Cell Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Engineered Cell Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Engineered Cell Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Engineered Cell Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Engineered Cell Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Engineered Cell Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Engineered Cell Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Engineered Cell Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Engineered Cell Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Engineered Cell Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Engineered Cell Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Engineered Cell Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Engineered Cell Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Engineered Cell Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Engineered Cell Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Engineered Cell Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Engineered Cell Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Engineered Cell Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Engineered Cell Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. Medtronic Basic Information List
Table 32. Medtronic Description and Business Overview
Table 33. Medtronic Engineered Cell Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Engineered Cell Therapy Business of Medtronic (2019-2024)
Table 35. Medtronic Recent Developments
Table 36. Stryker Basic Information List
Table 37. Stryker Description and Business Overview
Table 38. Stryker Engineered Cell Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Engineered Cell Therapy Business of Stryker (2019-2024)
Table 40. Stryker Recent Developments
Table 41. Zimmer Inc. Basic Information List
Table 42. Zimmer Inc. Description and Business Overview
Table 43. Zimmer Inc. Engineered Cell Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Engineered Cell Therapy Business of Zimmer Inc. (2019-2024)
Table 45. Zimmer Inc. Recent Developments
Table 46. Acelity Basic Information List
Table 47. Acelity Description and Business Overview
Table 48. Acelity Engineered Cell Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Engineered Cell Therapy Business of Acelity (2019-2024)
Table 50. Acelity Recent Developments
Table 51. Allergan Basic Information List
Table 52. Allergan Description and Business Overview
Table 53. Allergan Engineered Cell Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Engineered Cell Therapy Business of Allergan (2019-2024)
Table 55. Allergan Recent Developments
Table 56. Cook Medical Basic Information List
Table 57. Cook Medical Description and Business Overview
Table 58. Cook Medical Engineered Cell Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Engineered Cell Therapy Business of Cook Medical (2019-2024)
Table 60. Cook Medical Recent Developments
Table 61. Baxter International Basic Information List
Table 62. Baxter International Description and Business Overview
Table 63. Baxter International Engineered Cell Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Engineered Cell Therapy Business of Baxter International (2019-2024)
Table 65. Baxter International Recent Developments
Table 66. Organovo Holdings Inc Basic Information List
Table 67. Organovo Holdings Inc Description and Business Overview
Table 68. Organovo Holdings Inc Engineered Cell Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Engineered Cell Therapy Business of Organovo Holdings Inc (2019-2024)
Table 70. Organovo Holdings Inc Recent Developments
Table 71. Integra LifeSciences Basic Information List
Table 72. Integra LifeSciences Description and Business Overview
Table 73. Integra LifeSciences Engineered Cell Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Engineered Cell Therapy Business of Integra LifeSciences (2019-2024)
Table 75. Integra LifeSciences Recent Developments
Table 76. DePuy Synthes Basic Information List
Table 77. DePuy Synthes Description and Business Overview
Table 78. DePuy Synthes Engineered Cell Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Engineered Cell Therapy Business of DePuy Synthes (2019-2024)
Table 80. DePuy Synthes Recent Developments
Table 81. B. Braun Melsungen AG Basic Information List
Table 82. B. Braun Melsungen AG Description and Business Overview
Table 83. B. Braun Melsungen AG Engineered Cell Therapy Products, Services and Solutions
Table 84. Revenue (US$ Million) in Engineered Cell Therapy Business of B. Braun Melsungen AG (2019-2024)
Table 85. B. Braun Melsungen AG Recent Developments
Table 86. AbbVie Basic Information List
Table 87. AbbVie Description and Business Overview
Table 88. AbbVie Engineered Cell Therapy Products, Services and Solutions
Table 89. Revenue (US$ Million) in Engineered Cell Therapy Business of AbbVie (2019-2024)
Table 90. AbbVie Recent Developments
Table 91. Becton Basic Information List
Table 92. Becton Description and Business Overview
Table 93. Becton Engineered Cell Therapy Products, Services and Solutions
Table 94. Revenue (US$ Million) in Engineered Cell Therapy Business of Becton (2019-2024)
Table 95. Becton Recent Developments
Table 96. Dickinson and Company Basic Information List
Table 97. Dickinson and Company Description and Business Overview
Table 98. Dickinson and Company Engineered Cell Therapy Products, Services and Solutions
Table 99. Revenue (US$ Million) in Engineered Cell Therapy Business of Dickinson and Company (2019-2024)
Table 100. Dickinson and Company Recent Developments
Table 101. Organogenesis Inc. Basic Information List
Table 102. Organogenesis Inc. Description and Business Overview
Table 103. Organogenesis Inc. Engineered Cell Therapy Products, Services and Solutions
Table 104. Revenue (US$ Million) in Engineered Cell Therapy Business of Organogenesis Inc. (2019-2024)
Table 105. Organogenesis Inc. Recent Developments
Table 106. Athersys Inc. Basic Information List
Table 107. Athersys Inc. Description and Business Overview
Table 108. Athersys Inc. Engineered Cell Therapy Products, Services and Solutions
Table 109. Revenue (US$ Million) in Engineered Cell Therapy Business of Athersys Inc. (2019-2024)
Table 110. Athersys Inc. Recent Developments
Table 111. ReproCell Inc. Basic Information List
Table 112. ReproCell Inc. Description and Business Overview
Table 113. ReproCell Inc. Engineered Cell Therapy Products, Services and Solutions
Table 114. Revenue (US$ Million) in Engineered Cell Therapy Business of ReproCell Inc. (2019-2024)
Table 115. ReproCell Inc. Recent Developments
Table 116. RTI Surgical Inc. Basic Information List
Table 117. RTI Surgical Inc. Description and Business Overview
Table 118. RTI Surgical Inc. Engineered Cell Therapy Products, Services and Solutions
Table 119. Revenue (US$ Million) in Engineered Cell Therapy Business of RTI Surgical Inc. (2019-2024)
Table 120. RTI Surgical Inc. Recent Developments
Table 121. Tissue Regenix Group Plc Basic Information List
Table 122. Tissue Regenix Group Plc Description and Business Overview
Table 123. Tissue Regenix Group Plc Engineered Cell Therapy Products, Services and Solutions
Table 124. Revenue (US$ Million) in Engineered Cell Therapy Business of Tissue Regenix Group Plc (2019-2024)
Table 125. Tissue Regenix Group Plc Recent Developments
Table 126. RepliCel. Basic Information List
Table 127. RepliCel. Description and Business Overview
Table 128. RepliCel. Engineered Cell Therapy Products, Services and Solutions
Table 129. Revenue (US$ Million) in Engineered Cell Therapy Business of RepliCel. (2019-2024)
Table 130. RepliCel. Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Engineered Cell Therapy Downstream Customers
Table 134. Engineered Cell Therapy Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Engineered Cell Therapy Product Picture
Figure 2. Global Engineered Cell Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Engineered Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Engineered Cell Therapy Report Years Considered
Figure 5. Global Engineered Cell Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Engineered Cell Therapy Revenue in 2023
Figure 7. Engineered Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Synthetic Picture
Figure 9. Biologically Derived Picture
Figure 10. Others Picture
Figure 11. Global Engineered Cell Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Engineered Cell Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Research Institutes
Figure 14. Product Picture of Biotechnological Organizations
Figure 15. Product Picture of Diagnostic Centres
Figure 16. Global Engineered Cell Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Engineered Cell Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Engineered Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Engineered Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Engineered Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Engineered Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Engineered Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Engineered Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Engineered Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Engineered Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Engineered Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Engineered Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Engineered Cell Therapy Sales Value (%), (2019-2030)
Figure 29. United States Engineered Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Engineered Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Engineered Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Engineered Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Engineered Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Engineered Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 35. China Engineered Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Engineered Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 37. China Engineered Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Engineered Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Engineered Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Engineered Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Engineered Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Engineered Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Engineered Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Engineered Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Engineered Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Engineered Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 47. India Engineered Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Engineered Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 49. India Engineered Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 50. Engineered Cell Therapy Industrial Chain
Figure 51. Engineered Cell Therapy Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
